Cosmo Pharmaceuticals Fair Value
CO
The fair market value of COPN.SW stock is 243.18 CHF. Relative to the market price of 64.5 CHF Cosmo Pharmaceuticals is undervalued by 277%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Cosmo Pharmaceuticals Valuation
Current COPN.SW share ticker price is 64.5 CHF.
The fair value level of 243.18 CHF can be considered as an effective entry point for long-term investors to start investing in COPN.SW stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 277% lower its fair value
Current price is 29% lower its minimum value
Current price is 2673% lower its maximum value
Market price:
COPN.SW stock is greatly undervalued
It means the current price may concern as a Low Risk Entry Point
Cosmo Pharmaceuticals NV Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
400
2
Median P/E over 5 years
54.38
3
Minimum P/E over 5 years
18.62
4
Earning per share (last 12 months)
4.77 EUR
Maximum value
1
x
4
=
1 788.69 CHF
Fair value
2
x
4
=
243.18 CHF
Minimum value
3
x
4
=
83.27 CHF
Cosmo Pharmaceuticals NV price metrics
-2.29
Annual return (geometric mean)
32.16
Risk (standard deviation) of returns
β
0.76
Beta (volatility compared to market)